Michael Sun

564 total citations
35 papers, 277 citations indexed

About

Michael Sun is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Michael Sun has authored 35 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 21 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Michael Sun's work include Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Medical Imaging Techniques and Applications (4 papers). Michael Sun is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Medical Imaging Techniques and Applications (4 papers). Michael Sun collaborates with scholars based in United States, Pakistan and Puerto Rico. Michael Sun's co-authors include Muhammad Junaid Niaz, Scott T. Tagawa, Joseph R. Osborne, Neil H. Bander, David M. Nanus, Ana M. Molina, Charlene Thomas, Marigdalia K. Ramirez‐Fort, Jones T. Nauseef and Cora N. Sternberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Michael Sun

33 papers receiving 275 citations

Peers

Countries citing papers authored by Michael Sun

Since Specialization

Citations

This map shows the geographic impact of Michael Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sun more than expected).

Fields of papers citing papers by Michael Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sun. The network helps show where Michael Sun may publish in the future.

Co-authorship network of co-authors of Michael Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sun. A scholar is included among the top collaborators of Michael Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sun. Michael Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advances in PSMA-Targeted Radionuclide Therapeutics 2025 ·Current Treatment Options in Oncology ·(unknown), (unknown), Michael Sun, (unknown), Joseph R. Osborne, Scott T. Tagawa	1
2	Baseline Imaging Derived Factors of Response Following [225Ac]Ac‐J591 Therapy in Metastatic Castration‐Resistant Prostate Cancer: A Lesion Level Analysis 2025 ·The Prostate ·Judith Stangl‐Kremser, (unknown), (unknown), Alexander Martinez‐Fundichely, Michael Sun, Joseph R. Osborne, Jones T. Nauseef, Scott T. Tagawa, Neil H. Bander	1
3	Abstract 7582: Descriptive analysis of patients with mCRPC and liver metastases receiving alpha and beta PSMA targeted radionuclide therapy (PSMA-TRT) 2024 ·Cancer Research ·(unknown), Michael Sun, (unknown), Jones T. Nauseef, (unknown), Joseph Thomas, (unknown), Ana M. Molina, Cora N. Sternberg, (unknown), (unknown), Sarah Y. Yuan, Edward K. Fung, (unknown), (unknown), David M. Nanus, Joseph R. Osborne, Neil H. Bander, Scott T. Tagawa	1
4	Transcranial focused ultrasound selectively increases perfusion and modulates functional connectivity of deep brain regions in humans 2023 ·Frontiers in Neural Circuits ·Taylor Kuhn, Norman M. Spivak, (unknown), Sergio Becerra, (unknown), (unknown), Benjamin M. Rosenberg, Sonja Hiller, (unknown), (unknown), (unknown), Michael Sun, (unknown), (unknown), (unknown), Nanthia Suthana, Martin M. Monti, Susan Y. Bookheimer	25
5	Prognostic value of neutrophil‐to‐lymphocyte ratio in patients with metastatic castration‐resistant prostate cancer receiving prostate‐specific membrane antigen targeted radionuclide therapy 2023 ·The Prostate ·Judith Stangl‐Kremser, Michael Sun, (unknown), Joseph Thomas, Jones T. Nauseef, Joseph R. Osborne, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Neil H. Bander, Scott T. Tagawa	8
6	Response to RL‐225Ac in prostate cancer: Effect of prior treatment with RL‐177Lu: A systematic review of the literature 2023 ·The Prostate ·Judith Stangl‐Kremser, (unknown), (unknown), Joseph R. Osborne, Michael Sun, Scott T. Tagawa, Neil H. Bander	10
7	SUCCESSFUL THROMBOLYSIS OF AN INTERATRIAL THROMBUS DURING WATCHMAN LAAO 2023 ·Journal of the American College of Cardiology ·(unknown), Michael Sun, (unknown), (unknown), (unknown), (unknown), (unknown)	0
8	Antibody-drug conjugates for urothelial carcinoma 2023 ·Urologic Oncology Seminars and Original Investigations ·Joseph Thomas, Michael Sun, (unknown), (unknown), Jones T. Nauseef, Scott T. Tagawa	13
9	Management of Sleep and Fatigue in Gastrointestinal Patients 2022 ·Gastroenterology Clinics of North America ·Jessica K. Salwen‐Deremer, Michael Sun	2
10	Assessment of patient-reported outcomes (PROs) and longer-term adverse events (AEs) in phase I study of ²²⁵Ac-J591-PSMA for metastatic castration-resistant prostate cancer (mCRPC). 2022 ·Journal of Clinical Oncology ·Jones T. Nauseef, Charlene Thomas, (unknown), (unknown), Brian D. Gonzalez, Michael Sun, Oliver Sartor, Sharon Singh, (unknown), (unknown), (unknown), (unknown), (unknown), Shankar Vallabhajosula, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Joseph R. Osborne, Neil H. Bander, Scott T. Tagawa	2
11	Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer 2021 ·Frontiers in Oncology ·Panagiotis J. Vlachostergios, Muhammad Junaid Niaz, Michael Sun, (unknown), Charlene Thomas, Paul J. Christos, Joseph R. Osborne, Ana M. Molina, David M. Nanus, Neil H. Bander, Scott T. Tagawa	34
12	Review of commonly used prostate specific PET tracers used in prostate cancer imaging in current clinical practice 2021 ·Clinical Imaging ·Muhammad Junaid Niaz, Michael Sun, (unknown), (unknown), Jana Ivanidze, Joseph R. Osborne, (unknown)	12
13	Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC). 2021 ·Journal of Clinical Oncology ·Michael Sun, (unknown), Jones T. Nauseef, Muhammad Junaid Niaz, (unknown), (unknown), (unknown), (unknown), Panagiotis J. Vlachostergios, Joseph R. Osborne, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Neil H. Bander, Scott T. Tagawa	1
14	Loss of an Immunodominant HLA-Α 01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment 2021 ·Blood* ·Neal Flomenberg, Dolores Grosso, Yuri Sykulev, (unknown), Yanping Huang, Michael Sun, (unknown), (unknown), (unknown), Julie Katz Karp, Phyllis Flomenberg, (unknown), Patricia C. Henwood, Kristin L. Rising, Neda Nikbakht, (unknown), (unknown), (unknown), John L. Wagner	1
15	Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer 2020 ·Cureus ·Michael Sun, (unknown), (unknown), (unknown), Muhammad Junaid Niaz	34
16	Review of Lutetium-177-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for the Treatment of Metastatic Castration-resistant Prostate Cancer 2020 ·Cureus ·(unknown), Michael Sun, Marigdalia K. Ramirez‐Fort, Muhammad Junaid Niaz	11
17	Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes 2020 ·Biology of Blood and Marrow Transplantation ·Dolores Grosso, Matthew Carabasi, Joanne Filicko-O’Hara, John L. Wagner, (unknown), Michael Sun, Beth Colombe, Wenyin Shi, Maria Werner‐Wasik, (unknown), Önder Alpdoğan, Adam Binder, Margaret Kasner, Thomas R. Klumpp, Ubaldo Martinez‐Outschoorn, Neil Palmisiano, Lindsay Wilde, Pierluigi Porcu, Usama Gergis, Neal Flomenberg	3
18	Prostate-specific Membrane Antigen Based Antibody-drug Conjugates for Metastatic Castration-resistance Prostate Cancer 2020 ·Cureus ·(unknown), Michael Sun, Marigdalia K. Ramirez‐Fort, Muhammad Junaid Niaz	15
19	Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT) 2017 ·Blood ·Jason Chen, (unknown), John L. Wagner, Michael Sun, Önder Alpdoğan, Matthew Carabasi, Joanne Filicko-O’Hara, Sameh Gaballa, Margaret Kasner, Thomas R. Klumpp, Neil Palmisiano, Ubaldo Martinez‐Outschoorn, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso	1
20	Pineal germ cell tumors: Two cases with review of histopathologies and biomarkers 2017 ·Journal of Clinical Neuroscience ·Daniel T. Nagasawa, Carlito Lagman, Michael Sun, Andrew Yew, Lawrance K. Chung, Seung Joon Lee, Timothy T. Bui, Yinn Cher Ooi, Aaron Robison, Gabriel Zada, Isaac Yang	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact